TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 2 | 1 | 3 | 4 | 46 | 12 | 53 | 41 | -12 | 24 |
| P | %wins | 67 | 67 | 33 | 67 | 100 | 0 | 56 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
10/21/16 18:16 | 10/19/16 | BIOC | Biocept Inc | DE | Health | Health | Medical Laboratories | Huebner Bruce A | CA | D | P.d | 22 | 1.10 | 0 | 20 | 500 | 24 | D | -89 | -87 | -76 | -48 | -46 | -39 | -29 | 7 | 6 | 7 | -3 | 58 | 82 | ||
2/18/15 14:02 | 2/13/15 | BIOC | Biocept Inc | DE | Health | Health | Medical Laboratories | Huebner Bruce A | CA | D | P.d | 15 | 1.25 | 0 | 12 | New | 12 | D | -85 | -70 | -60 | -44 | -39 | -21 | 16 | 10 | 144 | 65 | 116 | 34 | -1 | ||
11/17/11 14:23 | 11/15/11 | VRML | Vermillion, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Huebner Bruce A | TX | D | P.m | 53 | 1.70 | 0 | 31 | 326 | 40 | D | -92 | -71 | -65 | -43 | -22 | -26 | -15 | 26 | -4 | -14 | -27 | -15 | 7 | -23 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |